We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $47.88 · 8 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Ascentage Pharma (AAPG) Unveils Promising Phase Ib Study Results - GuruFocus
Ascentage Pharma (AAPG) Unveils Promising Phase Ib Study Results GuruFocus
AAPG Stock Price, Quote & Chart | ASCENTAGE PHARMA GR-ADR (NASDAQ:AAPG) - ChartMill
AAPG Stock Price, Quote & Chart | ASCENTAGE PHARMA GR-ADR (NASDAQ:AAPG) ChartMill
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 03. 25. | After market close (AMC) | $-0.58 | — | — | $132.29M | — | Scheduled |
Compare a firm's past rating changes and its actions on other stocks in the same sector.
Price data
Filings, earnings, and institutional changes summarized in one paragraph, with source links.
No holdings data to show.
See new positions, full exits, and weight changes.